Qingyu Zong

644 total citations
25 papers, 529 citations indexed

About

Qingyu Zong is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Qingyu Zong has authored 25 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 13 papers in Biomaterials and 9 papers in Molecular Biology. Recurrent topics in Qingyu Zong's work include Nanoplatforms for cancer theranostics (21 papers), Nanoparticle-Based Drug Delivery (13 papers) and Graphene and Nanomaterials Applications (5 papers). Qingyu Zong is often cited by papers focused on Nanoplatforms for cancer theranostics (21 papers), Nanoparticle-Based Drug Delivery (13 papers) and Graphene and Nanomaterials Applications (5 papers). Qingyu Zong collaborates with scholars based in China, India and Russia. Qingyu Zong's co-authors include Youyong Yuan, Kewei Wang, Xuan Xiao, Yalan Tu, Maolin Jiang, Yansong Dong, Ye Liu, Ye Liu, Jun Li and Xinqing Jiang and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Qingyu Zong

25 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyu Zong China 15 345 187 182 132 82 25 529
Shiqi Hu China 11 272 0.8× 261 1.4× 236 1.3× 112 0.8× 65 0.8× 19 601
Die Jia China 13 377 1.1× 310 1.7× 170 0.9× 126 1.0× 59 0.7× 14 595
Fathelrahman Mohammed China 9 321 0.9× 217 1.2× 118 0.6× 153 1.2× 58 0.7× 9 447
Yalan Tu China 12 364 1.1× 174 0.9× 210 1.2× 121 0.9× 126 1.5× 17 589
Joungyoun Noh South Korea 11 423 1.2× 210 1.1× 243 1.3× 227 1.7× 89 1.1× 11 764
Krzysztof Sztandera Poland 9 307 0.9× 218 1.2× 183 1.0× 228 1.7× 61 0.7× 12 655
Chang Du China 13 436 1.3× 236 1.3× 154 0.8× 188 1.4× 56 0.7× 19 558
Sensen Zhou China 14 508 1.5× 216 1.2× 237 1.3× 250 1.9× 82 1.0× 27 806
Xiangjie Luo China 16 314 0.9× 137 0.7× 223 1.2× 196 1.5× 57 0.7× 37 601
Jiawei Huo China 10 279 0.8× 163 0.9× 105 0.6× 174 1.3× 64 0.8× 19 554

Countries citing papers authored by Qingyu Zong

Since Specialization
Citations

This map shows the geographic impact of Qingyu Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Zong more than expected).

Fields of papers citing papers by Qingyu Zong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Zong. The network helps show where Qingyu Zong may publish in the future.

Co-authorship network of co-authors of Qingyu Zong

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Zong. A scholar is included among the top collaborators of Qingyu Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Zong. Qingyu Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Tao, et al.. (2025). Non-invasive in vivo monitoring of PROTAC-mediated protein degradation using an environment-sensitive reporter. Nature Communications. 16(1). 1892–1892. 7 indexed citations
3.
Wang, Kewei, Maolin Jiang, Ye Liu, et al.. (2024). A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation. Advanced Materials. 36(30). e2402322–e2402322. 16 indexed citations
4.
Zong, Qingyu, Maolin Jiang, Wenjie Tang, et al.. (2024). Self-assembled metal–phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy. Biomaterials Science. 12(14). 3649–3658. 4 indexed citations
5.
Zong, Qingyu, et al.. (2024). Self-immolative poly(thiocarbamate) with localized H2S signal amplification for precise cancer imaging and therapy. Nature Communications. 15(1). 7558–7558. 19 indexed citations
6.
Zong, Qingyu, Dan Zhang, Wenhua Liang, et al.. (2024). Self-Adaptive Nanocarriers Overcome Multiple Physiological Barriers to Boosting Chemotherapy of Orthotopic Pancreatic Cancer. ACS Nano. 19(1). 662–679. 8 indexed citations
7.
Zong, Qingyu, et al.. (2023). Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging. Chemical Communications. 59(26). 3878–3881. 14 indexed citations
8.
Zong, Qingyu, et al.. (2022). Self-amplified chain-shattering cinnamaldehyde-based poly(thioacetal) boosts cancer chemo-immunotherapy. Acta Biomaterialia. 154. 97–107. 28 indexed citations
9.
Wang, Kewei, Maolin Jiang, Yansong Dong, et al.. (2022). Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity. Journal of Controlled Release. 348. 1004–1015. 8 indexed citations
10.
Xiao, Xuan, et al.. (2022). Tumor-Selective Cascade-Amplified Dual-Prodrugs Activation for Synergistic Oxidation-Chemotherapy. CCS Chemistry. 4(12). 3878–3888. 9 indexed citations
11.
Tu, Yalan, Xuan Xiao, Yansong Dong, et al.. (2022). Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy. Biomaterials. 289. 121795–121795. 54 indexed citations
12.
Zong, Qingyu, et al.. (2022). Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy. Biomaterials Science. 10(15). 4228–4234. 2 indexed citations
13.
Wang, Kewei, Xuan Xiao, Ye Liu, et al.. (2022). Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy. Biomaterials. 289. 121803–121803. 25 indexed citations
14.
Zong, Qingyu, Kewei Wang, Xuan Xiao, et al.. (2021). Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal. Biomaterials. 276. 121005–121005. 34 indexed citations
15.
Zong, Qingyu, et al.. (2021). Dual-locking nanoprobe based on hemicyanine for orthogonal stimuli-triggered precise cancer imaging and therapy. Journal of Controlled Release. 338. 307–315. 17 indexed citations
16.
Jiang, Maolin, Kewei Wang, Xuan Xiao, et al.. (2021). Theranostic Heterodimeric Prodrug with Dual‐Channel Fluorescence Turn‐On and Dual‐Prodrug Activation for Synergistic Cancer Therapy. Advanced Healthcare Materials. 10(21). e2101144–e2101144. 14 indexed citations
17.
Xiao, Xuan, Kewei Wang, Qingyu Zong, et al.. (2021). Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal. Biomaterials. 270. 120649–120649. 63 indexed citations
18.
Liu, Ye, Maolin Jiang, Yalan Tu, et al.. (2021). Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy. Biomaterials. 278. 121136–121136. 18 indexed citations
19.
Wang, Kewei, Yalan Tu, Yao Wang, et al.. (2020). Size-Switchable Nanoparticles with Self-Destructive and Tumor Penetration Characteristics for Site-Specific Phototherapy of Cancer. ACS Applied Materials & Interfaces. 12(6). 6933–6943. 51 indexed citations
20.
Xiao, Yu, Shuang Wang, Qingyu Zong, & Zongning Yin. (2018). Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy. AAPS PharmSciTech. 19(5). 2395–2406. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiqi Hu Breakdown of academic impact, for papers by Die Jia Breakdown of academic impact, for papers by Fathelrahman Mohammed Breakdown of academic impact, for papers by Yalan Tu Breakdown of academic impact, for papers by Joungyoun Noh Breakdown of academic impact, for papers by Krzysztof Sztandera Breakdown of academic impact, for papers by Chang Du Breakdown of academic impact, for papers by Sensen Zhou Breakdown of academic impact, for papers by Xiangjie Luo Breakdown of academic impact, for papers by Jiawei Huo
Rankless by CCL
2026